You just read:

People with Advanced Renal Cell Carcinoma in Sweden, Norway, Denmark and Finland Now Able to Benefit from Kisplyx® (Lenvatinib) in Combination with everolimus

News provided by

Eisai

17 Oct, 2016, 23:01 BST